World's Best Scientists 2026 revealed!
Toshihiko Torigoe

Toshihiko Torigoe

D-Index & Metrics

Microbiology

D-Index
67
Citations
17821
World Ranking
2255
National Ranking
74

Toshihiko Torigoe publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Toshihiko Torigoe sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 265 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 234 scientists 205–214 publications: 208 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 399 publications — 90th percentile

90% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Toshihiko Torigoe D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Toshihiko Torigoe sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 112 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 123 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 94 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 67 D-Index — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Toshihiko Torigoe is affiliated with Sapporo Medical University in Japan. Their research primarily focuses on medicine, with significant contributions in immunology and microbiology. Their work spans multiple subfields including oncology, immunology, molecular biology, surgery, and radiology, nuclear medicine, and imaging.

The scientist's prominent research topics include cancer immunotherapy and biomarkers, immunotherapy and immune responses, immune cell function and interaction, CAR-T cell therapy research, bladder and urothelial cancer treatments, monoclonal and polyclonal antibodies research, as well as vaccines and immunoinformatics approaches.

Frequent coauthors collaborating with Toshihiko Torigoe include:

  • Yoshihiko Hirohashi (91 joint works)
  • Takayuki Kanaseki (65 joint works)
  • Tomohide Tsukahara (54 joint works)
  • Terufumi Kubo (44 joint works)
  • Kenji Murata (33 joint works)

Key publication venues for Torigoe's work reflect a focus on cancer and immunological research, with frequent publications in:

  • Cancer Science (9 publications)
  • Cancers (8 publications)
  • Anticancer Research (8 publications)
  • Medical Molecular Morphology (6 publications)
  • Immunological Medicine (5 publications)

Significant recent papers by Toshihiko Torigoe include:

  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer, 2020, Journal of Clinical Oncology
  • Expression of classical human leukocyte antigen class I antigens, HLA-E and HLA-G, is adversely prognostic in pancreatic cancer patients, 2020, Cancer Science
  • HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite Instability, 2021, Gastroenterology
  • Prognostic value of FoxP3 and CTLA-4 expression in patients with oral squamous cell carcinoma, 2020, PLoS ONE
  • A screening assistance system for cervical cytology of squamous cell atypia based on a two-step combined CNN algorithm with label smoothing, 2021, Cancer Medicine

Best Publications

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma.

    Hiroyuki Komori;Tetsuya Nakatsura;Satoru Senju;Yoshihiro Yoshitake

  • Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.

    Hiroko Asanuma;Toshihiko Torigoe;Kenjiro Kamiguchi;Yoshihiko Hirohashi

  • An HLA-A24-restricted Cytotoxic T Lymphocyte Epitope of a Tumor-associated Protein, Survivin

    Yoshihiko Hirohashi;Toshihiko Torigoe;Akiko Maeda;Yuki Nabeta

  • Aberrant Expression and Potency as a Cancer Immunotherapy Target of Inhibitor of Apoptosis Protein Family, Livin/ML-IAP in Lung Cancer

    Hiroyuki Hariu;Yoshihiko Hirohashi;Toshihiko Torigoe;Hiroko Asanuma

  • RNA helicase YTHDC2 promotes cancer metastasis via the enhancement of the efficiency by which HIF-1α mRNA is translated

    Atsushi Tanabe;Kenya Tanikawa;Mai Tsunetomi;Kaori Takai

  • Effects of p56lck deficiency on the growth and cytolytic effector function of an interleukin-2-dependent cytotoxic T-cell line.

    Larry Karnitz;Shari L. Sutor;Toshihiko Torigoe;John C. Reed

  • Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

    Tetsuhiro Tsuruma;Fumitake Hata;Toshihiko Torigoe;Tomohisa Furuhata

  • CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection

    Noriyuki Yamada;Satoshi Oizumi;Eiki Kikuchi;Naofumi Shinagawa

  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

    Bernhard Mlecnik;Carlo Bifulco;Gabriela Bindea;Gabriela Bindea;Florence Marliot

  • Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma.

    Satoshi Kawaguchi;Takuro Wada;Kazunori Ida;Yuriko Sato

  • Detection of autoantibodies to livin and survivin in Sera from lung cancer patients.

    Atsuhito Yagihashi;Koichi Asanuma;Daisuke Kobayashi;Naoki Tsuji

  • Prognostic significance of HLA class I expression in osteosarcoma defined by anti‐pan HLA class I monoclonal antibody, EMR8‐5

    Tomohide Tsukahara;Satoshi Kawaguchi;Toshihiko Torigoe;Hiroko Asanuma

  • A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins

    Satomi Idenoue;Yoshihiko Hirohashi;Toshihiko Torigoe;Yuriko Sato

  • Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene.

    R. Yamada;A. Takahashi;T. Torigoe;R. Morita

  • Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas

    M Murase;M Kano;T Tsukahara;A Takahashi

  • Interleukin-3 regulates the activity of the LYN protein-tyrosine kinase in myeloid-committed leukemic cell lines

    Toshihiko Torigoe;Rosemary O’Connor;Daniela Santoli;John C. Reed

  • Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients.

    Jun-ichi Kobayashi;Toshihiko Torigoe;Yoshihiko Hirohashi;Satomi Idenoue

  • Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated RAF-1 kinase in a T-cell line.

    C V Clevenger;T Torigoe;J C Reed

  • Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells.

    Satoko Inoda;Yoshihiko Hirohashi;Toshihiko Torigoe;Rena Morita

Frequent Co-Authors

Noriyuki Sato
Noriyuki Sato Sapporo Medical University
Yoshihiko Hirohashi
Yoshihiko Hirohashi Sapporo Medical University
Koichi Hirata
Koichi Hirata Sapporo Medical University
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Yutaka Kawakami
Yutaka Kawakami International University Of Health And Welfare Atami Hospital
Alessandro Lugli
Alessandro Lugli University of Bern
Iris D. Nagtegaal
Iris D. Nagtegaal Radboud University
Pamela S. Ohashi
Pamela S. Ohashi Princess Margaret Cancer Centre
Paolo A. Ascierto
Paolo A. Ascierto National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology opens doors to diverse career paths, especially when combined with complementary skills in healthcare management and coding. For those interested in medical data and health records, becoming a certified professional coder is a popular option. Earning a professional coder certification can enhance employment opportunities in healthcare administration and billing.

Another promising field is health information management. Professionals with a master in health information management salary often enjoy strong financial rewards and job stability. This degree equips graduates with skills to oversee medical data systems, a growing need as healthcare technology expands.

For students looking for flexibility, pursuing an accredited online health information management degree cahiim ensures rigorous education through programs recognized by the leading accreditation body, CAHIIM. These programs blend microbiology knowledge with health information expertise, ideal for modern healthcare environments.

Additionally, quickly entering the workforce is possible through an accredited fast medical billing and coding certificate online. This pathway offers a streamlined education to start careers in billing and coding, linking well with microbiology and lab-based professions that require familiarity with medical records and billing systems.

Best Scientists Citing Toshihiko Torigoe

Trending Scientists

Recently Published Articles